Brand-Name Iron Preparations
The most commonly available brand-name iron preparations include oral formulations such as ferrous sulfate (generic), ferrous fumarate (Ferro-Sequels, Ferretts), and ferrous gluconate (Fergon), along with newer agents like ferric citrate (Auryxia), ferric maltol (Feraccru/Accrufer), and liposomal iron (Ferrolip, SiderAL Forte); for intravenous therapy, key formulations include iron sucrose (Venofer), ferric carboxymaltose (Ferinject/Injectafer), ferric derisomaltose (Monofer/Monoferric), ferumoxytol (Rienso/Feraheme), sodium ferric gluconate (Ferrlecit), and low-molecular-weight iron dextran (Cosmofer/INFeD). 1, 2, 1, 3
Oral Iron Preparations
Traditional Ferrous Salts
- Ferrous sulfate (generic): 65 mg elemental iron per 325 mg tablet, remains the gold standard and most cost-effective option at $0.30-$4.50 per 30 pills 2, 3, 4
- Ferrous fumarate (Ferro-Sequels, Ferretts, Ferrimin, Hemocyte): 106-150 mg elemental iron per tablet, approximately $3.90 per 30 pills 1, 3
- Ferrous gluconate (Fergon, Ferate): 27-38 mg elemental iron per tablet, $1.50-$3.30 per 30 pills 2, 1, 3
Newer Oral Formulations
- Ferric citrate (Auryxia [USA], Riona [Japan], Nephoxil [Taiwan]): 210 mg elemental iron per 1g tablet in US formulation; shown to increase hemoglobin while lowering phosphate and FGF23 levels 1
- Ferric maltol (Feraccru [Europe], Accrufer [USA]): 30 mg elemental iron per capsule, lipophilic iron donor with potentially improved tolerability 1, 5
- Liposomal iron (Ferrolip, SiderAL Forte [Europe]): 30 mg elemental iron per capsule, bypasses hepcidin-ferroportin block through M-cell uptake 1
- Ferrous bisglycinate: 25 mg elemental iron per tablet, approximately $2.40 per 30 pills, associated with fewer GI complaints than conventional formulations 3, 6
- Polysaccharide-iron complex: Variable iron content listed in product name, approximately $4.20 per 30 pills 3
- Heme iron polypeptide (Proferrin [USA]): 12 mg elemental iron per tablet 1
Intravenous Iron Preparations
High-Dose Formulations (Allow Total Dose Infusion)
Ferric carboxymaltose (Ferinject [Europe], Injectafer [USA]): 50 mg/mL concentration, maximum single dose 1000 mg (EMA) or 750 mg (FDA), 15-minute infusion time, cost approximately $3,470 for typical dosing 1, 2, 3, 7
Ferric derisomaltose/Iron isomaltoside (Monofer [Europe], Monoferric [USA]): 100 mg/mL concentration, maximum 20 mg/kg (EMA) or 1000 mg (FDA), only formulation with FDA-approved total dose infusion label, cost approximately $3,896 1, 7
Low-molecular-weight iron dextran (Cosmofer [Europe], INFeD [USA]): 50 mg/mL concentration, maximum 20 mg/kg, 4-6 hour total infusion time, cost approximately $405; can also be given intramuscularly though this is painful 1, 2, 3
- Safety concern: Historical serious reaction rate 0.6-0.7% with 31 fatalities reported 1976-1996 2
Ferumoxytol (Rienso [Europe], Feraheme [USA]): 30 mg/mL concentration, 510-1020 mg dosing, 15-minute infusion, cost approximately $1,963 1, 3, 7
Lower-Dose Formulations (Require Multiple Administrations)
Iron sucrose (Venofer); Iron sucrose similars (FerMed): 20 mg/mL concentration, maximum 200 mg single dose, 500 mg weekly maximum, 10-30 minute infusion, cost approximately $441.50 for typical course 1, 2, 3
Sodium ferric gluconate (Ferrlecit): 12.5 mg/mL concentration, maximum 125 mg single dose, 60-minute infusion (FDA), cost approximately $610 for typical course 1, 3
Ferric pyrophosphate citrate: Recently FDA-approved at time of 2021 KDIGO guidelines 1
Key Clinical Considerations
Oral iron dosing: Effective repletion requires 100-200 mg elemental iron daily for 3-12 weeks, continued for 3 months after correction to replenish stores 2, 4. Lower doses may be equally effective with better tolerability 2.
IV iron safety: All formulations carry <1% risk of moderate-to-severe infusion reactions; resuscitation facilities must be available 2, 7, 8. Avoid diphenhydramine for reactions as side effects can mimic worsening symptoms 3.
Monitoring after IV iron: Check CBC and iron parameters (ferritin, TSAT) 4-8 weeks after last infusion; avoid testing within 4 weeks as circulating iron interferes with assays 7. Monitor phosphate levels, especially with ferric carboxymaltose 1, 3, 8.